Dario Amodei defends Anthropic's safety record against Nathan Calvin's critique
Article timeline
The articles in this story. Times are ET.
Andrew CurranXDario Amodei defends Anthropic's safety record against critic's list of concernsAIDario Amodei replies to Nathan Calvin's critique of Anthropic and says the company's costly safety actions outweigh the criticisms. He cites its role in SB53, strict biological safeguards, delayed release of Mythos-class models, and restrictions on sales to PRC-controlled companies. He says some criticized items were ordinary frontier competition, admits communication lapses, and defends the RSP change as part of a race to the top strategy.
Dario AmodeiXAmodei defends Anthropic's "race to the top" strategy against safety criticismAIDario Amodei says Anthropic's safety-focused strategy of building frontier AI responsibly to raise industry standards remains sound, despite criticism from Nathan Calvin. He cites commercially costly steps over the past year, including backing California's SB53, maintaining strict biological safeguards that produce false positives, and delaying general release of Mythos-class models until June to focus on cyberdefense.